Hantz Financial Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Hantz Financial Services's EW Position: Q2 2026 in Review
Hantz Financial Services increased its Edwards Lifesciences (EW) stake by 29% in Q2 2026, buying an estimated $33.6K and bringing the position to 1,788 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #1200.
Hantz Financial Services first reported a position in EW in Q4 2020 and has held it in 23 quarters since. The position peaked at $577K in Q3 2023. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Hantz Financial Services held 1,788 shares of Edwards Lifesciences worth $162K as of Q2 2026.
- Hantz Financial Services bought 401 Edwards Lifesciences shares in Q2 2026, an estimated $33.6K.
- Edwards Lifesciences made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1200 holding.
- Hantz Financial Services first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 23 quarters since.
- Hantz Financial Services's Edwards Lifesciences position peaked at $577K in Q3 2023.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.